An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new opportunity to determine whether polymorphisms, mutations, and splice variants identified in cancer cells are translated. Herein, we apply a proteogenomic data integration tool (QUILTS) to illustrate protein variant discovery using whole genome, whole transcriptome, and global proteome datasets generated from a pair of luminal and basal-like breast-cancer-patient-derived xenografts (PDX). The sensitivity of proteogenomic analysis for singe nucleotide variant (SNV) expression and novel splice junction (NSJ) detection was probed using multiple MS/MS sample process replicates defined here as an independent tandem MS experiment using identical sample material. Despite analysis of over 30 sample process replicates, only about 10% of SNVs (somatic and germline) detected by both DNA and RNA sequencing were observed as peptides. An even smaller proportion of peptides corresponding to NSJ observed by RNA sequencing were detected (<0.1%). Peptides mapping to DNA-detected SNVs without a detectable mRNA transcript were also observed, suggesting that transcriptome coverage was incomplete (∼80%). In contrast to germline variants, somatic variants were less likely to be detected at the peptide level in the basal-like tumor than in the luminal tumor, raising the possibility of differential translation or protein degradation effects. In conclusion, this large-scale proteogenomic integration allowed us to determine the degree to which mutations are translated and identify gaps in sequence coverage, thereby benchmarking current technology and progress toward whole cancer proteome and transcriptome analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
Self-citationAssigning Significance to Peptides Identified by Tandem Mass Spectrometry Using Decoy Databases
Käll, L., Storey, J. D., MacCoss, M. J., & Noble, W. S. (2008) · Journal of Proteome Research · doi:10.1021/pr700600n · Cited by 607 · cited 1×
“(22) and was controlled for at a q-value of 0.”
BackgroundProtein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data
Wang, X., Slebos, R. J. C., Wang, D., Halvey, P. J., Tabb, D. L., Liebler, D. C., & Zhang, B. (2012) · Journal of Proteome Research · doi:10.1021/pr200766z · Cited by 173 · cited 1×
“our protein sequence database, increasing the number of tumor-specific peptides that can be identified by tandem MS (2, 5, 9).”
BackgroundSelf-citationDe novo derivation of proteomes from transcriptomes for transcript and protein identification
Evans, V. C., Barker, G., Heesom, K. J., Fan, J., Bessant, C., & Matthews, D. A. (2012) · Nature Methods · doi:10.1038/nmeth.2227 · Cited by 166 · cited 1×
“Integrated proteogenomic methodologies have been successfully implemented in several model systems, including mouse and human cell lines (2, 4-7), and in other model systems for gene annotation (3, 8-10).”
MethodDiscovery and mass spectrometric analysis of novel splice-junction peptides using RNA-Seq
Sheynkman, G. M., Shortreed, M. R., Frey, B. L., & Smith, L. M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.028142 · Cited by 128 · cited 5×
“6 an unbiased and comprehensive way to profoundly understand the aberrant information flux that underlies all cancer biology (2-5).”
BackgroundMethodInfluential
Research works printed but not linked: 26
- Cirulli, 2010, Screening the human exome: A comparison of whole genome and whole transcriptome sequencing, Genome Biol, 11, R57, 10.1186/gb-2010-11-5-r57 · DOI · Paper page
- Castellana, 2013, An automated proteogenomic method utilizes mass spectrometry to reveal novel genes in Zea mays, Mol. Cell. Proteomics, 13, 157, 10.1074/mcp.M113.031260 · DOI
- Li, 2011, A bioinformatics workflow for variant peptide detection in shotgun proteomics, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.006536 · DOI
- Omenn, 2010, Alternative splice variants, a new class of protein cancer biomarker candidates: Findings in pancreatic cancer and breast cancer with systems biology implications, Disease Markers, 28, 241, 10.1155/2010/705847 · DOI
- Adamidi, 2011, De novo assembly and validation of planaria transcriptome by massive parallel sequencing and shotgun proteomics, Genome Res, 21, 1193, 10.1101/gr.113779.110 · DOI · Paper page
- Woo, 2013, Proteogenomic database construction driven from large scale RNA-seq data, J. Proteome Res, 13, 21, 10.1021/pr400294c · DOI · Paper page
- Xing, 2011, The discovery of novel protein-coding features in mouse genome based on mass spectrometry data, Genomics, 98, 343, 10.1016/j.ygeno.2011.07.005 · DOI
- Parker, 2009, Supervised risk predictor of breast cancer based on intrinsic subtypes, J. Clin. Oncol, 27, 1160, 10.1200/JCO.2008.18.1370 · DOI · Paper page
- Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 · DOI · Paper page
- Ding, 2010, Genome remodelling in a basal-like breast cancer metastasis and xenograft, Nature, 464, 999, 10.1038/nature08989 · DOI · Paper page
- Li, 2013, Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts, Cell reports, 4, 1116, 10.1016/j.celrep.2013.08.022 · DOI · Paper page
- Mertins, 2014, Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels, Mol. Cell. Proteomics, 13, 1690, 10.1074/mcp.M113.036392 · DOI · Paper page
- Koboldt, 2009, VarScan: Variant detection in massively parallel sequencing of individual and pooled samples, Bioinformatics, 25, 2283, 10.1093/bioinformatics/btp373 · DOI · Paper page
- McKenna, 2010, The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, 20, 1297, 10.1101/gr.107524.110 · DOI · Paper page
- Ye, 2009, Pindel: A pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads, Bioinformatics, 25, 2865, 10.1093/bioinformatics/btp394 · DOI · Paper page
- Kim, 2011, TopHat-Fusion: An algorithm for discovery of novel fusion transcripts, Genome Biol, 12, R72, 10.1186/gb-2011-12-8-r72 · DOI · Paper page
- Perkins, 1999, Probability-based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis, 20, 3551, 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 · DOI · Paper page
- Nesvizhskii, 2014, Proteogenomics: Concepts, applications and computational strategies, Nat. Methods, 11, 1114, 10.1038/nmeth.3144 · DOI · Paper page
- Gaudet, 2015, The neXtProt knowledgebase on human proteins: Current status, Nucleic Acids Res, 43, D764, 10.1093/nar/gku1178 · DOI · Paper page
- Kuperwasser, 2004, Reconstruction of functionally normal and malignant human breast tissues in mice, Proc. Natl. Acad. Sci. U. S. A, 101, 4966, 10.1073/pnas.0401064101 · DOI · Paper page
- Craig, 2005, The use of proteotypic peptide libraries for protein identification, Rapid Commun. Mass Spectrom, 19, 1844, 10.1002/rcm.1992 · DOI · Paper page
- Piskol, 2013, Reliable identification of genomic variants from RNA-seq data, Am. J. Human Genetics, 93, 641, 10.1016/j.ajhg.2013.08.008 · DOI · Paper page
- Balmain, 2003, The genetics and genomics of cancer, Nat. Genetics, 33, 238, 10.1038/ng1107 · DOI · Paper page
- Ning, 2010, The utility of mass spectrometry-based proteomic data for validation of novel alternative splice forms reconstructed from RNA-Seq data: A preliminary assessment, BMC Bioinformatics, 11, S14, 10.1186/1471-2105-11-S11-S14 · DOI · Paper page
- Huang, 2005, Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns, Anal. Chem, 77, 5800, 10.1021/ac0480949 · DOI · Paper page
- Eriksson, 2007, Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs, Nature Biotechnol, 25, 651, 10.1038/nbt1315 · DOI
Cited by
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Self-citationIntegrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029
Self-citationHow many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Self-citationProteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Self-citationIntegrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730
“Creation of a Patient-Specific Protein Sequence Database: The proteogenomic database tool pyQUILTS (Ruggles et al., 2016), available at http://quilts.”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., Mertins, P., Slebos, R., Erdmann-Gilmore, P., Li, S., Gunawardena, H. P., Xie, L., Liu, T., Zhou, J.-Y., Sun, S., Hoadley, K. A., Perou, C. M., Chen, X., Davies, S. R., Maher, C. A., Kinsinger, C. R., Rodland, K. D., Zhang, H., Zhang, Z., Ding, L., Townsend, R. R., Rodriguez, H., Chan, D., Smith, R. D., Liebler, D. C., Carr, S. A., Payne, S., Ellis, M. J., & Fenyő, D.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 15
- Issue
- 3
- Pages
- 1060-1071
- ISSN
- 1535-9476 (ISSN-L)
- OpenAlex
- W2182676712
- Cited by
- 118
- References
- 5
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1658 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.